TriSalus Life Sciences (TLSIW) Other Working Capital Changes (2021 - 2026)
TriSalus Life Sciences (TLSIW) reported Other Working Capital Changes of $423000.0 for Q1 2026, up 182.78% on a YoY basis from $149586.9 in Q1 2025, and up 320.31% quarter-over-quarter from -$192000.0 in Q4 2025.
TriSalus Life Sciences (TLSIW) Other Working Capital Changes (2021 - 2026) Analysis & Trends
TriSalus Life Sciences has reported Other Working Capital Changes for 6 years, with the latest figure at $423000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 182.78% year-over-year to $423000.0; the trailing twelve-month figure through Mar 2026 stood at $94000.0 (down 43.37% YoY), and the FY2025 full-year result was -$840000.0, down 202.16% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $423000.0, up from -$192000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $3.0 million in Q2 2024, with the low at -$2.6 million in Q4 2024.
- Historically, Other Working Capital Changes has averaged -$62529.4 across 5 years, with a median of -$72000.0 in 2023.
- The largest YoY upside for Other Working Capital Changes was 2174.81% in 2024 against a maximum downside of 1226.39% in 2024.
- TriSalus Life Sciences' Other Working Capital Changes stood at -$125000.0 in 2022, then surged by 708.0% to $760000.0 in 2023, then slumped by 442.24% to -$2.6 million in 2024, then jumped by 92.62% to -$192000.0 in 2025, then soared by 320.31% to $423000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $423000.0 (Q1 2026), -$192000.0 (Q4 2025), and -$567000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | TriSalus Life Sciences | - | - | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 423,000.00 |
| Mar 31, 2026 | 423,000.00 |
| Dec 31, 2025 | -192,000.00 |
| Dec 31, 2025 | -192,000.00 |
| Sep 30, 2025 | -567,000.00 |
| Sep 30, 2025 | -567,000.00 |
| Jun 30, 2025 | 430,000.00 |
| Jun 30, 2025 | 430,000.00 |
| Mar 31, 2025 | -511,000.00 |
| Mar 31, 2025 | -511,000.00 |
| Dec 31, 2024 | -2.60 Mn |
| Dec 31, 2024 | -2.60 Mn |
| Sep 30, 2024 | 298,000.00 |
| Sep 30, 2024 | 298,000.00 |
| Jun 30, 2024 | 2.98 Mn |
| Jun 30, 2024 | 2.98 Mn |
| Mar 31, 2024 | -955,000.00 |
| Mar 31, 2024 | -955,000.00 |
| Dec 31, 2023 | 760,000.00 |
| Dec 31, 2023 | 760,000.00 |